-
Get the Answers You Need
Whether you are newly diagnosed or a long-term survivor, LUNGevity offers lung cancer support and survivorship services to address your unique needs. LUNGevity's services are... -
Introduction to Radiation Therapy
Lung cancer survivor Jill Feldman joins radiation therapy experts Drs. Drew Moghanaki and Kristin Higgins to provide an overview of radiation therapy – including discussions of... -
Caregiver Starter Kit: 5 Resources
Navigating a lung cancer diagnosis can feel overwhelming not only to the patient but to their caregiver as well. It’s normal to feel lost or confused and not know where to start or... -
World Lung Cancer Day and the Changing Landscape of Lung Cancer
For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000... -
Key Findings from ASCO 2022
Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, speaks with Charles Rudin, MD, PhD, about the key findings from the recent meeting of the American Society for... -
We're Live-Tweeting from ASCO June 3-7!
LUNGevity’s Dr. Upal Basu Roy and Dr. Amy Moore will be live-tweeting from the American Society of Clinical Oncology (ASCO) annual meeting. Follow LUNGevity on Twitter and the... -
Lung Cancer Treatment Landscape: New Options and Ongoing Challenges
Drs. Upal Basu Roy, Amy Moore, and Dhru Deb discuss their recent publication in which they presented an analysis of the lung cancer drug pipeline. They talk about what it means for... -
Facebook Live: A Conversation with the EGFR Resisters Patient Group
Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, chats with Jill Feldman and Ivy Elkins, co-founders of the EGFR Resisters; and Drs. Christine Lovly, MD, PhD... -
Tips for Better Sleep
Sleep tips session with our sleep expert, Peggy Burhenn. -
New Options in Adjuvant Therapy for Early-Stage NSCLC
Historically, surgery has been the most effective treatment for patients with early-stage non-small cell lung cancer (NSCLC). While technological improvements, such as the... -
Studying Drug Resistance From a New Angle
The development of “targeted therapies” which block the function of mutant proteins within tumor cells has revolutionized the treatment landscape for many cancers, most of all lung... -
Highlights of the 2022 AACR meeting
The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in...
EGFR